Author Correction: Retargeted oncolytic viruses engineered to remodel the tumor microenvironment for glioblastoma immunotherapy.
Saved in:
| Title: | Author Correction: Retargeted oncolytic viruses engineered to remodel the tumor microenvironment for glioblastoma immunotherapy. |
|---|---|
| Authors: | Giovannoni F; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Strathdee CA; Oncorus, Inc., Andover, MA, USA., Faust Akl C; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Faculty of Biology, University of Freiburg, Freiburg, Germany., Andersen BM; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Department of Neurology, Veterans Affairs Medical Center, Harvard Medical School, Boston, MA, USA., Li Z; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Lee HG; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Torti MF; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Rone JM; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Duart-Abadia P; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Molgora M; Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA., Kong L; Oncorus, Inc., Andover, MA, USA., Floyd M; Oncorus, Inc., Andover, MA, USA., Teng J; Oncorus, Inc., Andover, MA, USA., Gyulakian Y; Oncorus, Inc., Andover, MA, USA., Grzesik P; Oncorus, Inc., Andover, MA, USA., Farkaly T; Oncorus, Inc., Andover, MA, USA., Denslow A; Oncorus, Inc., Andover, MA, USA., Feau S; Oncorus, Inc., Andover, MA, USA., Rodriguez-Sanchez I; Oncorus, Inc., Andover, MA, USA., Jacques J; Oncorus, Inc., Andover, MA, USA., Colonna M; Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA., Kennedy EM; Oncorus, Inc., Andover, MA, USA., Cheema T; Oncorus, Inc., Andover, MA, USA., Lerner L; Oncorus, Inc., Andover, MA, USA., Quéva C; Oncorus, Inc., Andover, MA, USA. christophe@ovietx.com., Quintana FJ; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. fquintana@rics.bwh.harvard.edu.; Broad Institute of MIT and Harvard, Cambridge, MA, USA. fquintana@rics.bwh.harvard.edu.; The Gene Lay Institute of Immunology and Inflammation, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. fquintana@rics.bwh.harvard.edu. |
| Source: | Nature cancer [Nat Cancer] 2026 Jan; Vol. 7 (1), pp. 247. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print Cited Medium: Internet ISSN: 2662-1347 (Electronic) Linking ISSN: 26621347 NLM ISO Abbreviation: Nat Cancer Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
